Eam Global Investors LLC Veracyte, Inc. Transaction History

Eam Global Investors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$20.78 - $29.99 $1.09 Million - $1.57 Million	-52,273 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$23.87 - $30.93 $1.11 Million - $1.43 Million	-46,310 Reduced 46.98%	52,273 $1.26 Million
Q2 2019 Aug 14, 2019	SELL	$22.1 - $28.56 $555,792 - $718,255	-25,149 Reduced 20.33%	98,583 $2.81 Million
Q4 2018 Feb 13, 2019	BUY	$9.15 - $14.85 $263,812 - $428,155	28,832 Added 30.38%	123,732 $1.56 Million
Q3 2018 Nov 08, 2018	BUY	$9.55 - $12.64 $906,295 - $1.2 Million	94,900 New	94,900 $906,000

338

76.8M

212K

18.5K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.23B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.